CAPR EBITDA | CAPRICOR THERAPEUTICS, INC.

CAPRICOR THERAPEUTICS, INC. (CAPR) EBITDA

2026-06-30: Basis Reported; EBITDA -$42.38M*; Operating income -$42.95M; Depreciation and amortization $561.85K*.
2026-03-31: Basis Reported; EBITDA -$36.24M; Operating income (m); Depreciation and amortization (m).
2025-12-31: Basis Reported; EBITDA -$28.65M; Operating income (m); Depreciation and amortization (m).
2025-09-30: Basis Reported; EBITDA -$25.79M*; Operating income -$26.28M; Depreciation and amortization $494.73K*.

Complete source-backed ebitda history.

Available history: 2010-12-31 to 2026-03-31
Data captured: 2026-09-04

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Reported	-$42.38M*	-$42.95M	$561.85K*	(m)	(m)	$4.06M*	-$31.49M*	(m)	$28.87M	(m)	$1.60K
2026-03-31	Reported	-$36.24M	(m)	(m)	(m)	(m)	$5.12M	-$29.25M	(m)	$27.38M	(m)	$0.00
2025-12-31	Reported	-$28.65M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2025-09-30	Reported	-$25.79M*	-$26.28M	$494.73K*	(m)	(m)	$55.84K*	-$19.69M*	(m)	$20.36M	(m)	(m)
2025-06-30	Reported	-$27.23M*	-$27.72M	$486.28K*	(m)	(m)	$287.74K*	-$20.12M*	(m)	$22.05M	(m)	$1.60K
2025-03-31	Reported	-$24.58M	(m)	(m)	(m)	(m)	$896.01K	-$6.43M	(m)	$18.92M	(m)	$0.00
2024-12-31	Reported	-$7.32M	(m)	(m)	(m)	-65.77%	(m)	(m)	(m)	(m)	(m)	(m)
2024-09-30	Reported	-$12.65M*	-$13.01M	$361.17K*	(m)	(m)	$9.14K*	-$11.64M*	(m)	$11.81M	(m)	(m)
2024-06-30	Reported	-$11.23M*	-$11.59M	$356.94K*	(m)	(m)	$60.34K*	-$12.29M*	(m)	$12.50M	(m)	(m)
2024-03-31	Reported	-$9.93M	(m)	(m)	(m)	-202.46%	$608.59K	-$1.27M	(m)	$11.10M	(m)	(m)
2023-12-31	Reported	-$973,684.00	(m)	(m)	(m)	-8.05%	(m)	(m)	(m)	(m)	(m)	(m)
2023-09-30	Reported	-$6.59M*	-$6.86M	$276.47K*	(m)	(m)	$269.49K*	-$8.79M*	(m)	$10.03M	(m)	(m)
2023-06-30	Reported	-$7.49M*	-$7.75M	$254.70K*	(m)	(m)	$135.87K*	-$9.42M*	(m)	$8.82M	(m)	(m)
2023-03-31	Reported	-$7.95M	(m)	(m)	(m)	-266.33%	$347.69K	$4.21M	(m)	$7.66M	(m)	(m)
2022-12-31	Reported	-$7.87M	(m)	(m)	(m)	-820.37%	(m)	(m)	(m)	(m)	(m)	(m)
2022-09-30	Reported	-$6.34M*	-$6.48M	$137.03K*	(m)	(m)	$557.62K*	-$5.69M*	(m)	$5.50M	(m)	(m)
2022-06-30	Reported	-$7.21M*	-$7.32M	$112.01K*	(m)	(m)	$180.96K*	-$6.54M*	(m)	$4.97M	(m)	(m)
2022-03-31	Reported	-$7.74M	(m)	(m)	(m)	(m)	$567.62K	$24.05M	(m)	$5.12M	(m)	(m)
2021-12-31	Reported	-$6.3M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2021-09-30	Reported	-$4.25M*	-$4.31M	$64.72K*	(m)	(m)	$468.24K*	-$3.34M*	(m)	$2.51M	(m)	(m)
2021-06-30	Reported	-$5.03M*	-$5.08M	$52.20K*	(m)	(m)	$322.46K*	-$4.51M*	(m)	$3.50M	(m)	(m)
2021-03-31	Reported	-$5.11M	(m)	(m)	(m)	-12521.93%	$36.91K	-$3.33M	(m)	$3.30M	(m)	(m)
2020-12-31	Reported	-$4.14M	(m)	(m)	(m)	-7156.26%	(m)	(m)	(m)	(m)	(m)	(m)
2020-09-30	Reported	-$3.88M*	-$3.91M	$36.20K*	(m)	(m)	$152.02K*	-$2.98M*	(m)	$2.63M	(m)	(m)
2020-06-30	Reported	-$3.46M*	-$3.49M	$32.64K*	(m)	(m)	$107.46K*	-$2.02M*	(m)	$1.93M	(m)	(m)
2020-03-31	Reported	-$2.07M	(m)	(m)	(m)	-1117.18%	$0.00	-$1.22M	(m)	$1.16M	(m)	(m)
2019-12-31	Reported	-$1.44M	(m)	(m)	(m)	-648.65%	(m)	(m)	(m)	(m)	(m)	(m)
2019-09-30	Reported	-$1.58M*	-$1.63M	$42.84K*	(m)	(m)	$0.00*	-$1.65M*	(m)	$857.76K	(m)	(m)
2019-06-30	Reported	-$2.02M*	-$2.07M	$43.11K*	(m)	(m)	$0.00*	-$1.78M*	(m)	$1.64M	(m)	(m)
2019-03-31	Reported	-$2.51M	(m)	(m)	(m)	-1090.60%	$0.00	-$1.61M	(m)	$1.81M	(m)	(m)
2018-12-31	Reported	-$3.26M	(m)	(m)	(m)	-503.43%	(m)	(m)	(m)	(m)	(m)	(m)
2018-09-30	Reported	-$4.13M*	-$4.17M	$41.40K*	(m)	(m)	$145.46K*	-$2.98M*	(m)	$3.13M	(m)	(m)
2018-06-30	Reported	-$4.12M*	-$4.16M	$38.90K*	(m)	(m)	$238.00*	-$3.69M*	(m)	$3.39M	(m)	(m)
2018-03-31	Reported	-$3.65M	(m)	(m)	(m)	-912.88%	$186.39K	-$3.42M	(m)	$2.70M	(m)	(m)
2017-12-31	Reported	-$3.25M	(m)	(m)	(m)	-682.19%	(m)	(m)	(m)	(m)	(m)	(m)
2017-09-30	Reported	-$2.60M*	-$2.64M	$33.54K*	(m)	(m)	$16.35K*	-$3.19M*	(m)	$1.86M	(m)	(m)
2017-06-30	Reported	-$3.34M*	-$3.38M	$37.28K*	(m)	(m)	$12.71K*	-$3.70M*	(m)	$3.13M	(m)	(m)
2017-03-31	Reported	-$3.53M	(m)	(m)	(m)	-400.41%	$3.13K	-$4.68M	(m)	$3.26M	(m)	(m)
2016-12-31	Reported	-$2.88M	(m)	(m)	(m)	-317.49%	(m)	(m)	(m)	(m)	(m)	(m)
2016-09-30	Reported	-$5.21M*	-$5.24M	$26.71K*	(m)	(m)	$10.75K*	(m)	(m)	$4.73M	(m)	(m)
2016-06-30	Reported	-$4.58M*	-$4.61M	$33.49K*	(m)	(m)	$29.86K*	(m)	(m)	$4.31M	(m)	(m)
2016-03-31	Reported	-$4.18M	(m)	(m)	(m)	-343.94%	$45.81K	(m)	(m)	$4.34M	(m)	(m)
2015-12-31	Reported	-$3.25M	(m)	(m)	(m)	-289.64%	(m)	(m)	(m)	(m)	(m)	(m)
2015-09-30	Reported	(m)	-$2.85M	(m)	(m)	(m)	(m)	(m)	(m)	$3.19M	(m)	(m)
2015-09-30	Reported	-$2.82M*	-$2.85M	$28.78K*	(m)	(m)	$73.62K*	(m)	(m)	$3.19M	(m)	(m)
2015-06-30	Reported	-$3.04M*	-$3.06M	$26.20K*	(m)	(m)	$23.30K*	(m)	(m)	$3.43M	(m)	(m)
2015-03-31	Reported	-$3.39M	(m)	(m)	(m)	-189.60%	$27.45K	(m)	(m)	$3.81M	(m)	(m)
2014-12-31	Reported	-$1.85M	(m)	(m)	(m)	-132.17%	(m)	(m)	(m)	(m)	(m)	(m)
2014-09-30	Reported	-$1.47M*	-$1.49M	$12.14K*	(m)	(m)	$30.23K*	(m)	(m)	$1.97M	(m)	(m)
2014-06-30	Reported	-$1.47M*	-$1.48M	$9.75K*	(m)	(m)	$23.55K*	(m)	(m)	$1.86M	(m)	(m)
2014-03-31	Reported	-$1.18M	(m)	(m)	(m)	-113.18%	$92.90K	(m)	(m)	$1.37M	(m)	(m)
2013-12-31	Reported	-$2.35M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2013-09-30	Reported	-$1.49M*	-$1.49M	$6.59K*	(m)	(m)	$15.05K*	-$158.18K*	(m)	$1.01M	(m)	(m)
2013-06-30	Reported	-$1.61M*	-$1.62M	$7.68K*	(m)	(m)	$34.12K*	-$55.83K*	(m)	$1.31M	(m)	(m)
2013-03-31	Reported	-$1.43M	(m)	(m)	(m)	-611.33%	$3.14K	-$144.18K	(m)	$1.19M	(m)	(m)
2012-12-31	Reported	$36,095.00	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2012-09-30	Reported	-$574.86K*	-$576.31K	$1.45K*	(m)	(m)	$0.00*	-$494.68K*	(m)	$179.14K	(m)	(m)
2012-06-30	Reported	-$772.86K*	-$774.42K	$1.56K*	(m)	(m)	$0.00*	-$852.75K*	(m)	$332.45K	(m)	(m)
2012-06-30	Reported	(m)	-$774.42K	(m)	(m)	(m)	(m)	(m)	(m)	$332.45K	(m)	(m)
2012-03-31	Reported	-$768,080.00	(m)	(m)	(m)	-392.88%	$0.00	-$603.46K	(m)	$465.35K	(m)	(m)
2011-12-31	Reported	-$1.66M	(m)	(m)	(m)	-850.81%	(m)	(m)	(m)	(m)	(m)	(m)
2011-09-30	Reported	-$1.15M*	-$1.16M	$1.81K*	(m)	(m)	(m)	-$652.50K*	(m)	$1.47M	(m)	(m)
2011-06-30	Reported	-$878.36K*	-$880.24K	$1.87K*	(m)	(m)	(m)	-$1.17M*	(m)	$702.93K	(m)	(m)
2011-03-31	Reported	-$1.2M	(m)	(m)	(m)	(m)	(m)	-$1.26M	(m)	$622.33K	(m)	(m)
2010-12-31	Reported	-$1.04M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2010-09-30	Reported	-$1.81M*	-$1.81M	$3.08K*	(m)	(m)	(m)	-$1.13M*	(m)	$1.15M	(m)	(m)
2010-06-30	Reported	(m)	-$1.50M	(m)	(m)	(m)	(m)	(m)	(m)	$1.06M	(m)	(m)

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2025-12-31	Reported	-$106.25M	(m)	(m)	(m)	(m)	$2.90M	-$69.81M	(m)	$84.45M	(m)	$1.60K
2024-12-31	Reported	-$41.14M	(m)	(m)	(m)	-184.72%	$1.17M	-$40.00M	(m)	$49.97M	(m)	$1.60K
2023-12-31	Reported	-$23.01M	(m)	(m)	(m)	-91.39%	$1.31M	-$25.60M	(m)	$36.45M	(m)	(m)
2022-12-31	Reported	-$29.16M	(m)	(m)	(m)	-1143.04%	$2.00M	$4.92M	(m)	$21.82M	(m)	(m)
2021-12-31	Reported	-$20.69M	(m)	(m)	(m)	-8449.54%	$1.20M	-$16.81M	(m)	$13.57M	(m)	(m)
2020-12-31	Reported	-$13.55M	(m)	(m)	(m)	-4366.18%	$547.60K	-$10.05M	(m)	$8.46M	(m)	(m)
2019-12-31	Reported	-$7.56M	(m)	(m)	(m)	-752.41%	$0.00	-$6.82M	(m)	$5.14M	(m)	(m)
2018-12-31	Reported	-$15.17M	(m)	(m)	(m)	-907.61%	$316.49K	-$13.86M	(m)	$12.07M	(m)	(m)
2017-12-31	Reported	-$12.72M	(m)	(m)	(m)	-476.99%	$32.19K	-$14.23M	(m)	$10.77M	(m)	(m)
2016-12-31	Reported	-$16.85M	(m)	(m)	(m)	-421.42%	$191.97K	-$14.45M	(m)	$16.04M	(m)	(m)
2015-12-31	Reported	-$12.5M	(m)	(m)	(m)	-226.56%	$129.70K	(m)	(m)	$13.76M	(m)	(m)
2014-12-31	Reported	-$5.98M	(m)	(m)	(m)	-124.85%	$162.69K	(m)	(m)	$7.79M	(m)	(m)
2013-12-31	Reported	-$6.88M	(m)	(m)	(m)	-1366.36%	$56.12K	(m)	(m)	$5.20M	(m)	(m)
2012-12-31	Reported	-$2.08M	(m)	(m)	(m)	-1063.79%	$13.43K	-$2.19M	(m)	$2.63M	(m)	$0.00
2011-12-31	Reported	-$4.89M	(m)	(m)	(m)	-361.14%	$1.99K	-$4.65M	(m)	$4.14M	(m)	(m)
2010-12-31	Reported	-$6.28M	(m)	(m)	(m)	(m)	$2.21K	-$4.32M	(m)	$4.08M	(m)	(m)

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
PUMA BIOTECHNOLOGY, INC. (PBYI)	United States	$0.507B	15.53
ARVINAS, INC. (ARVN)	United States	$0.510B	58.38
Ovid Therapeutics Inc. (OVID)	United States	$0.487B	-14.41
ASSEMBLY BIOSCIENCES, INC. (ASMB)	United States	$0.481B	-13,053.96
Evolus, Inc. (EOLS)	United States	$0.519B	-13.32
CRESCENT BIOPHARMA, INC. (CBIO)	United States	$0.529B	-5.20
Indaptus Therapeutics, Inc. (INDP)	United States	$0.537B
MapLight Therapeutics, Inc. (MPLT)	United States	$0.459B	-7.10
Quoin Pharmaceuticals Ltd. (QNRX)		$0.443B	-17.85
CYPHERPUNK TECHNOLOGIES INC. (CYPH)	United States	$0.438B	-75.63